on-invasive bed-side measurement of systemic endothelial function in patients undergoing abdominal aortic aneurysm repair; modulation by ascorbic acid - AAAAA

Phase 1

• Conditions: Abdominal Aortic Aneurysm; MedDRA version: 9.1Level: LLTClassification code 10049871Term: Abdominal aortic aneurysm haemorrhage

• Registration Number: EUCTR2006-006887-44-GB
• Lead Sponsor: Royal Group Hospitals Trust

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2007-05-15
• Study Completion: 2013-09-21
• Last Update Posted: 13 October 2020

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: All
• Target Recruitment: 31

Inclusion Criteria

Adult patients admitted for elective open repair of AAA in the Royal Victoria Hospital, Belfast will be eligible for inclusion in the study.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Exclusion criteria will be prior antioxidant therapy, known allergy to ascorbic acid or agents specified in the standardised anaesthetic protocol and lack of consent.

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified